Keywords: psoriasis, candidate, may, cause, cancer, fda, usa-based

J&J psoriasis candidate may cause cancer; FDA

Article | 23 June 2008

• Print This

USA-based Centocor's experimental psoriasis drug, ustekinumab (CNTO 1275) may increase the risk of cancer, the Food and Drug Administration has said.

Enjoying this article? To continue reading you need to login or subscribe.